A comprehensive view of Combination Therapy. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Tissue & Hygiene Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

US Patent Issued to Bristol-Myers Squibb on April 23 for "Substituted bicyclic compounds useful as T cell activators" (American, Indian Inventors)
Published: April 24, 2024 by U.S. Fed News
US Patent Issued to Regeneron Pharmaceuticals on April 23 for "Methods and compositions for sensitization of tumor cells to immune therapy" (New York, New Jersey Inventors)
Published: April 24, 2024 by U.S. Fed News
US Patent Issued to REGENERON PHARMACEUTICALS on April 23 for "Combination of IL-4/IL-13 pathway inhibitors and plasma cell ablation for treating allergy" (New York Inventors)
Published: April 24, 2024 by U.S. Fed News
US Patent Issued to Bristol-Myers Squibb, Celldex Therapeutics on April 23 for "Use of anti-PD-1 antibody in combination with anti-CD27 antibody in cancer treatment" (Pennsylvania, Maryland, Connecticut Inventors)
Published: April 24, 2024 by U.S. Fed News
Study shows that withdrawing aspirin and keeping high-risk heart patients on ticagrelor a month after a percutaneous coronary intervention improves outcomes and reduces bleeding by over half; the findings may change worldwide standard of care guidelines
Published: April 23, 2024 by Insurance Daily News

Ask us about our Tissue & Hygiene market view

Trending Chart

Interactive chart with headline count